Your browser doesn't support javascript.
loading
Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021.
Tran Kiem, Cécile; Andronico, Alessio; Bosetti, Paolo; Paireau, Juliette; Alter, Lise; Boëlle, Pierre-Yves; Fontanet, Arnaud; Lévy-Bruhl, Daniel; Cauchemez, Simon.
Afiliação
  • Tran Kiem C; Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.
  • Andronico A; Collège Doctoral, Sorbonne Université, Paris, France.
  • Bosetti P; Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.
  • Paireau J; Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.
  • Alter L; Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.
  • Boëlle PY; Santé Publique France, French National Public Health Agency, Saint-Maurice, France.
  • Fontanet A; Haute Autorité de Santé, Saint-Denis la Plaine, France.
  • Lévy-Bruhl D; Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, INSERM, Paris, France.
  • Cauchemez S; Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France.
Euro Surveill ; 26(26)2021 07.
Article em En | MEDLINE | ID: mdl-34212840
Thrombosis with thrombocytopenia (TTS) has been identified as a rare adverse event following COVID-19 vaccination with Vaxzevria. We modelled the benefits and risks of Vaxzevria distribution from May to September 2021 in metropolitan France where other vaccines are available, considering French hospitalisation data and European data on TTS. Across different scenarios, benefits of Vaxzevria distribution in people 55 years and older exceeded the risk of death from COVID-19. In young adults, risks were at least of similar magnitude as benefits.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article